Interview: immunotherapeutic manipulation of the tumor microenvironment

Immunotherapy. 2013 Dec;5(12):1279-81. doi: 10.2217/imt.13.135.

Author

Dario A A Vignali¹

Affiliation

¹ Department of Immunology, St Jude Children's Research Hospital, 262 Danny Thomas Place, Memphis, TN 38105-3678, USA. vignali.lab@stjude.org.

PMID: 24283836
DOI: 10.2217/imt.13.135

No abstract available

Publication types

Interview
Research Support, Non-U.S. Gov't

MeSH terms

Antibodies, Monoclonal / pharmacology
Antibodies, Monoclonal / therapeutic use
Autoimmunity / drug effects
Autoimmunity / immunology*
Humans
Ipilimumab
Neoplasms / drug therapy
Neoplasms / immunology
Nivolumab
Signal Transduction / drug effects
Signal Transduction / immunology*
T-Lymphocytes, Regulatory / drug effects
T-Lymphocytes, Regulatory / immunology*
Tumor Microenvironment / drug effects
Tumor Microenvironment / immunology*

Substances

Antibodies, Monoclonal
Ipilimumab
Nivolumab